Management of ERTs in High-Risk Populations During COVID-19 Pandemic

Ari Zimran, MD, of the Shaare Zedek Medical Center, Israel talks about the impact the COVID-19 pandemic has had on treating patients with lysosomal storage disorders that require enzyme replacement therapies. 

This presentation was part of the live GRIDS 2020-Virtual Summit held July 1, 2020 and is now available exclusively on CheckRare. 

To view the entire session and receive CME credit, go to checkrare.com/learning/p-grids2020-module4-lysosomal-disease-management-and-covid-19/